| Literature DB >> 1732542 |
M Yamato1, J Ando, K Sakaki, K Hashigaki, Y Wataya, S Tsukagoshi, T Tashiro, T Tsuruo.
Abstract
Bistropolone derivatives (4-12) containing differing lengths of linkage between the two tropolone rings were prepared and examined for their antitumor activity in in vitro (KB cell) and in vivo (leukemia P388 in mice) systems. Parent compound 3, related compounds previously prepared, and the new compounds 4-12 were evaluated for inhibitory activity against ribonucleotide reductase by indirect means to measure their effects on the dNTP pool imbalance. Present structure-activity relationship results would suggest that potently active bistropolones in vivo inhibit intracellular ribonucleotide reductase through chelating with the two irons at the two active sites of the enzyme.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1732542 DOI: 10.1021/jm00080a010
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446